It also aimed to break even in its manufacturing and trading of animal health product business. For the first half of financial year ending Dec 31, 2021 (FY21), Sunzen’s revenue from its animal health product segment increased almost 10% year-on-year (y-o-y) to RM7.37mil. “Hopefully, our health product segment can break even soon. “Now, we want to focus on businesses where the market demand fundamentals are strong – which are the traditional Chinese medicine and the loan financing segments. On its animal health product segment, Sunzen told Bursa Malaysia that it plans to launch new products targeting the immune system for swine next month.

Source: The Star November 13, 2021 16:26 UTC